Description

Long-acting basal insulin analogue
Maintains normal physiological concentration of basal (baseline) insulin
Most widely used basal insulin analogue. It is a reference product for all basal insulins
Increased duration of action of insulin glargine is associated with subcutaneous microprecipitates generation from which smallamounts of insulin glargine permanently release, which makes it possible to administer the product once a day
Concentration: U100
Onest of action after subcutaneous administration in 1 hour
Maximum action in 29 hours
Duration of action - 24 hours.